In a medical breakthrough, a 25-year-old woman from China achieved insulin independence through a pioneering stem cell procedure that could transform the treatment landscape for type 1 diabetes. This ...

The Denosumab for Type 1 Diabetes phase 1/2 clinical trial, is a collaborative study with the Arthur Riggs Diabetes and ...

According to Precedence Research, the global stem cell therapy market size was valued at USD 14.15 billion in 2023 and is expected to hit around USD 48.89 billion by 2033 with a CAGR of 13.2% from ...

Consistent high-quality products are crucial as key raw materials for safe and reliable cell manufacturing. We adhere to ...

A groundbreaking discovery has recently brought hope to millions of people living with type 1 diabetes around the world. In a ...

Taiwan’s REGiMMUNE and Europe-based Kiji Therapeutics are merging to create a globally minded regulatory T-cell biotech that ...

Novo Nordisk scientists have synthesised an insulin molecule that specifically targets glucose in blood, instead of other sugars like fructose, to aid treatment of all types of diabetes.

Steroids, hyaluronic acid injections, and regenerative therapies, such as PRP and stem cell injections, are among the ...

Breakthrough stem cell transplants for diabetes have allowed patients to produce their own insulin, offering hope for a ...

Different trials involving stem cell therapy are on in India, but studies are long-term and risks like immune rejection need ...

'It is established that replacement islets can free a patient of diabetes from insulin dependency. Our goal is to make a highly allocompatible and off-the-shelf product available to the millions of ...